206 REFERENCES 1. Vanholder R, Fouque D, Glorieux G, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016;4(4):360-373. 10.1016/S2213-8587(16)00033-4 2. Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393-409. 10.1038/nrneph.2017.63 3. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13 Suppl 1:S37-S40. 4. European Statistics. European Statistical Office of the European Union (EUROSTAT). Accessed Dec 2022. https://ec.europa.eu/eurostat 5. Mohnen SM, van Oosten MJM, Los J, et al. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data. PLoS One. 2019;14(8). 10.1371/journal.pone.0220800 6. World Health Organization. Action plan for the prevention and control of noncommunicable diseases in the WHO European region. Copenhagen, Denmark. 2016. 7. Mihaylova B, Schlackow I, Herrington W, et al. Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016;67(4):576-584. 10.1053/j. ajkd.2015.09.020 8. Kindig DA, Panzer AM, Nielsen-Bohlman L. Introduction. In: Health Literacy: A Prescription to End Confusion. 1st ed. Washington DC, USA: National Academies Press; 2004. 9. Mackey LM, Doody C, Werner EL, et al. Self-management skills in chronic disease management: what role does health literacy have? Med Decis Making. 2016;36(6):741759. 10.1177/0272989X16638330 10. Taylor DM, Fraser S, Dudley C, et al. Health literacy and patient outcomes in chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2017;33(9):1545-1558. 10.1093/ndt/gfx293 11. Williams MV, Davis T, Parker RM, et al. The role of health literacy in patient-physician communication. Fam Med. 2002;34(5):383-389. 12. Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370(9604):2044-2053. 10.1016/S0140-6736(07)61698-5 13. Parrott S, Godfrey C. Economics of smoking cessation. BMJ. 2004;328(7445):947-949. 10.1136/bmj.328.7445.947 14. Guo J, Gibson J, Gropper D, et al. Empiric Investigation on Direct Costs-of-Illness and Healthcare. Am J Man Care. 1998;4:1433-1446. 15. Boonstra MD, Gurgel do Amaral M, Navis G, et al. Effectiveness of a health literacy intervention targeting both chronic kidney disease patients and health care professionals in primary and secondary care: a quasi-experimental study. [Accepted by Journal of Nephrology]. 16. Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150. 10.1038/ kisup.2012.73 17. Dutch National Health Care Institute [Zorginstituut Nederland]. Guideline for economic evaluations in healthcare. Diemen, The Netherlands. 2016. 18. Brouwer WBF, Niessen LW, Postma MJ, et al. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331(7514):446-448. 10.1136/ bmj.331.7514.446 19. Hakkaart-van Roijen L, van der Lindenc N, Bouwmans C, et al. Dutch National Health Care Institute [Zorginstituut Nederland]. Cost manual: Methodology of cost research and reference prices for economic evaluations in healthcare [Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg]. Diemen, The Netherlands. 2016. 20. Elmer PJ, Grimm R, Laing B, et al. Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med. 1995;24(4):378-388. 10.1006/pmed.1995.1063 21. Leading causes of death. Statistics Netherlands (CBS). Accessed Jan 2022. https:// www.cbs.nl/
RkJQdWJsaXNoZXIy MTk4NDMw